Global Pain Management Drugs Market Research Report 2017

Table of Contents

1 Pain Management Drugs Market Overview 1
1.1 Pain Management Drugs Product Overview 1
1.2 Pain Management Drugs Segment by Types (Product Category) 2
1.2.1 Global Pain Management Drugs Revenue Comparison by Types 2
1.2.2 Opioids 3
1.2.3 NSAIDs 4
1.3 Global Pain Management Drugs Segment by Applications 4
1.3.1 Global Pain Management Drugs Revenue Comparison by Applications 4
1.3.2 Hospitals 5
1.3.3 Drugstores 6
1.3.4 Clinic 6
1.4 Global Pain Management Drugs Market by Regions (2012-2022) 7
1.4.1 Global Pain Management Drugs Market Size and Growth Rate Comparison by Regions (2012-2022) 7
1.4.2 North America Pain Management Drugs Status and Prospect (2012-2022) 8
1.4.3 Europe Pain Management Drugs Status and Prospect (2012-2022) 9
1.4.4 Asia-Pacific Pain Management Drugs Status and Prospect (2012-2022) 10
1.4.5 South America Pain Management Drugs Status and Prospect (2012-2022) 11
1.4.6 Middle East and Africa Pain Management Drugs Status and Prospect (2012-2022) 12
1.5 Global Pain Management Drugs Market Size (2012-2022) 13
2 Global Pain Management Drugs Market Competition by Manufacturers 14
2.1 Global Pain Management Drugs Revenue and Share by Manufacturers (2016 and 2017) 14
2.2 Manufacturers Pain Management Drugs Headquarters, Established Date, Product Types 17
2.3 Pain Management Drugs Market Competitive Situation and Trends 19
2.3.1 Pain Management Drugs Market Concentration Rate 19
2.3.2 Pain Management Drugs Market Share of Top 3 and Top 5 Manufacturers 20
2.3.3 Mergers & Acquisitions, Expansion 21
3 Global Pain Management Drugs Revenue by Regions (2012-2017) 27
3.1 Global Pain Management Drugs Revenue and Market Share by Regions (2012-2017) 27
3.2 North America Pain Management Drugs Revenue (2012-2017) 30
3.2.1 North America Pain Management Drugs Revenue and Growth Rate (2012-2017) 30
3.2.2 North America Pain Management Drugs Revenue, Cost, Gross and Gross Margin (2012-2017) 30
3.3 Europe Pain Management Drugs Revenue (2012-2017) 31
3.3.1 Europe Pain Management Drugs Revenue and Growth Rate (2012-2017) 31
3.3.2 Europe Pain Management Drugs Revenue, Cost, Gross and Gross Margin (2012-2017) 31
3.4 Asia-Pacific Pain Management Drugs Revenue (2012-2017) 32
3.4.1 Asia-Pacific Pain Management Drugs Revenue and Growth Rate (2012-2017) 32
3.4.2 Asia-Pacific Pain Management Drugs Revenue, Cost, Gross and Gross Margin (2012-2017) 32
3.5 South America Pain Management Drugs Revenue (2012-2017) 33
3.5.1 South America Pain Management Drugs Revenue and Growth Rate (2012-2017) 33
3.5.2 South America Pain Management Drugs Revenue, Cost, Gross and Gross Margin (2012-2017) 33
3.6 Middle East and Africa Pain Management Drugs Revenue (2012-2017) 34
3.6.1 Middle East and Africa Pain Management Drugs Revenue and Growth Rate (2012-2017) 34
3.6.2 Middle East and Africa Pain Management Drugs Revenue, Cost, Gross and Gross Margin (2012-2017) 34
4 Global Pain Management Drugs Consumption by Regions (2012-2017) 35
4.1 Global Pain Management Drugs Consumption by Regions (2012-2017) 35
4.2 North America Pain Management Drugs Consumption (2012-2017) 38
4.3 Europe Pain Management Drugs Consumption (2012-2017) 39
4.4 Asia-Pacific Pain Management Drugs Consumption (2012-2017) 40
4.5 South America Pain Management Drugs Consumption (2012-2017) 41
4.6 Middle East and Africa Pain Management Drugs Consumption (2012-2017) 42
5 Global Pain Management Drugs Market Analysis by Types 43
5.1 Global Pain Management Drugs Revenue and Market Share by Types (2012-2017) 43
5.2 Global Pain Management Drugs Revenue Growth Rate by Types (2012-2017) 45
6 Global Pain Management Drugs Market Analysis by Applications 46
6.1 Global Pain Management Drugs Consumption and Market Share by Applications (2012-2017) 46
6.2 Global Pain Management Drugs Consumption Growth Rate by Applications (2012-2017) 49
7 Analysis of Pain Management Drugs Industry Key Manufacturers 50
7.1 Pfizer 50
7.1.1 Company Profile 50
7.1.2 Product Information 51
7.1.3 Revenue, Cost, Gross and Gross Margin 51
7.2 GSK 52
7.2.1 Company Profile 52
7.2.2 Product Information 53
7.2.3 Revenue, Cost, Gross and Gross Margin 54
7.3 Grunenthal 54
7.3.1 Company Profile 54
7.3.2 Product Information 55
7.3.3 Revenue, Cost, Gross and Gross Margin 55
7.4 Bayer 56
7.4.1 Company Profile 56
7.4.2 Product Information 57
7.4.3 Revenue, Cost, Gross and Gross Margin 57
7.5 Sanofi 58
7.5.1 Company Profile 58
7.5.2 Product Information 59
7.5.3 Revenue, Cost, Gross and Gross Margin 59
7.6 Eli Lilly 59
7.6.1 Company Profile 59
7.6.2 Product Information 61
7.6.3 Revenue, Cost, Gross and Gross Margin 61
7.7 AstraZeneca 62
7.7.1 Company Profile 62
7.7.2 Product Information 63
7.7.3 Revenue, Cost, Gross and Gross Margin 63
7.8 Endo 64
7.8.1 Company Profile 64
7.8.2 Product Information 65
7.8.3 Revenue, Cost, Gross and Gross Margin 65
7.9 Merck 66
7.9.1 Company Profile 66
7.9.2 Product Information 67
7.9.3 Revenue, Cost, Gross and Gross Margin 67
7.10 Depomed 68
7.10.1 Company Profile 68
7.10.2 Product Information 69
7.10.3 Revenue, Cost, Gross and Gross Margin 69
7.11 Yunnan Baiyao 70
7.11.1 Company Profile 70
7.11.2 Product Information 71
7.11.3 Revenue, Cost, Gross and Gross Margin 72
7.12 Teva 72
7.12.1 Company Profile 72
7.12.2 Product Information 73
7.12.3 Revenue, Cost, Gross and Gross Margin 73
7.13 J&J 74
7.13.1 Company Profile 74
7.13.2 Product Information 75
7.13.3 Revenue, Cost, Gross and Gross Margin 76
7.14 Allergan 76
7.14.1 Company Profile 76
7.14.2 Product Information 77
7.14.3 Revenue, Cost, Gross and Gross Margin 77
7.15 Purdue 78
7.15.1 Company Profile 78
7.15.2 Product Information 79
7.15.3 Revenue, Cost, Gross and Gross Margin 79
8 Pain Management Drugs Manufacturing Cost Analysis 80
8.1 Pain Management Drugs R&D Cost Analysis 80
8.1.1 Clinical Phase Costs 81
8.1.2 Capitalized Costs 82
8.2 Proportion of Manufacturing Cost Structure 83
8.2.1 Raw Materials 83
8.2.2 Labor Cost 83
8.2.3 Manufacturing Expenses 90
8.3 Manufacturing Process Analysis of Pain Management Drugs 91
9 Industrial Chain, Sourcing Strategy and Downstream Buyers 92
9.1 Pain Management Drugs Industrial Chain Analysis 92
9.2 Upstream Raw Materials Sourcing 93
9.3 Downstream Buyers 93
10 Marketing Strategy Analysis, Distributors/Traders 97
10.1 Marketing Channel 97
10.1.1 Direct Marketing 97
10.1.2 Indirect Marketing 98
10.2 Market Positioning 98
10.2.1 Pricing Strategy 98
10.2.2 Brand Strategy 99
10.3 Distributors/Traders List 101
11 Market Effect Factors Analysis 102
11.1 Technology Progress/Risk 102
11.1.1 Substitutes Threat 102
11.1.2 Technology Progress in Related Industry 102
11.2 Consumer Needs/Customer Preference Change 108
11.3 Economic/Political Environmental Change 108
12 Global Pain Management Drugs Market Forecast (2017-2022) 120
12.1 Global Pain Management Drugs Revenue Forecast (2017-2022) 120
12.2 Global Pain Management Drugs Revenue Forecast by Regions (2017-2022) 120
12.2.1 North America Pain Management Drugs Revenue Forecast (2017-2022) 123
12.2.2 Europe Pain Management Drugs Revenue Forecast (2017-2022) 124
12.2.3 Asia-Pacific Pain Management Drugs Revenue Forecast (2017-2022) 125
12.2.4 South America Pain Management Drugs Revenue Forecast (2017-2022) 126
12.2.5 Middle East and Africa Pain Management Drugs Revenue Forecast (2017-2022) 127
12.3 Global Pain Management Drugs Consumption Forecast by Regions (2017-2022) 127
12.3.1 North America Pain Management Drugs Consumption Forecast (2017-2022) 130
12.3.2 Europe Pain Management Drugs Consumption Forecast (2017-2022) 131
12.3.3 Asia-Pacific Pain Management Drugs Consumption Forecast (2017-2022) 132
12.3.4 South America Pain Management Drugs Consumption Forecast (2017-2022) 133
12.3.5 Middle East and Africa Pain Management Drugs Consumption Forecast (2017-2022) 134
12.4 Global Pain Management Drugs Revenue Forecast by Types (2017-2022) 134
12.5 Global Pain Management Drugs Consumption Forecast by Application (2017-2022) 136
13 Research Findings and Conclusion 139
14 Methodology and Data Source 140
14.1 Methodology/Research Approach 140
14.1.1 Research Programs/Design 140
14.1.2 Market Size Estimation 141
14.1.3 Market Breakdown and Data Triangulation 142
14.2 Data Source 143
14.2.1 Secondary Sources 143
14.2.2 Primary Sources 144
14.3 Disclaimer 145
14.4 Author List 146






List of Tables and Figures

Figure Product Picture of Pain Management Drugs 1
Table Classification of Pain Management Drugs 2
Figure Global Pain Management Drugs Revenue Market Share by Types in 2016 3
Figure Opioids Examples 3
Figure NSAIDs Examples 4
Table Applications of Pain Management Drugs 4
Figure Global Pain Management Drugs Consumption Value Market Share by Applications in 2016 5
Figure Hospitals Examples 5
Figure Drugstores Examples 6
Figure Clinic Examples 6
Figure Global Pain Management Drugs Revenue (M USD) Comparison by Regions (2012-2022) 7
Figure North America Pain Management Drugs Revenue (M USD) and Growth Rate (2012-2022) 8
Figure Europe Pain Management Drugs Revenue (M USD) and Growth Rate (2012-2022) 9
Figure Asia-Pacific Pain Management Drugs Revenue (M USD) and Growth Rate (2012-2022) 10
Figure South America Pain Management Drugs Revenue (M USD) and Growth Rate (2012-2022) 11
Figure Middle East and Africa Pain Management Drugs Revenue (M USD) and Growth Rate (2012-2022) 12
Figure Global Pain Management Drugs Revenue (M USD) Status and Outlook (2012-2022) 13
Table Global Pain Management Drugs Revenue (M USD) by Manufacturers (2016 and 2017) 14
Table Global Pain Management Drugs Revenue Market Share by Manufacturers (2016 and 2017) 14
Figure 2016 Global Pain Management Drugs Revenue Market Share by Manufacturers 16
Figure 2017 Global Pain Management Drugs Revenue Market Share by Manufacturers 17
Table Manufacturers Pain Management Drugs Headquarters and Established Date 17
Table Manufacturers Pain Management Drugs Product Category 18
Figure Pain Management Drugs Revenue Market Share in 2016 19
Figure Pain Management Drugs Revenue Market Share of Top 3 Manufacturers in 2016 20
Figure Pain Management Drugs Market Share of Top 5 Manufacturers in 2016 20
Table Mergers & Acquisitions, Expansion 21
Table Global Pain Management Drugs Revenue (M USD) by Regions (2012-2017) 27
Table Global Pain Management Drugs Revenue Market Share by Regions (2012-2017) 27
Figure Global Pain Management Drugs Revenue Market Share by Regions (2012-2017) 28
Figure 2012 Global Pain Management Drugs Revenue Market Share by Regions 28
Figure 2016 Global Pain Management Drugs Revenue Market Share by Regions 29
Table Global Pain Management Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin (2012-2017) 29
Figure North America Pain Management Drugs Revenue (M USD) and Growth Rate (2012-2017) 30
Table North America Pain Management Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin (2012-2017) 30
Figure Europe Pain Management Drugs Revenue (M USD) and Growth Rate (2012-2017) 31
Table Europe Pain Management Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin (2012-2017) 31
Figure Asia-Pacific Pain Management Drugs Revenue (M USD) and Growth Rate (2012-2017) 32
Table Asia-Pacific Pain Management Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin (2012-2017) 32
Figure South America Pain Management Drugs Revenue (M USD) and Growth Rate (2012-2017) 33
Table South America Pain Management Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin (2012-2017) 33
Figure Middle East and Africa Pain Management Drugs Revenue (M USD) and Growth Rate (2012-2017) 34
Table Middle East and Africa Pain Management Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin (2012-2017) 34
Table Global Pain Management Drugs Consumption Value (M USD) Market by Regions (2012-2017) 35
Table Global Pain Management Drugs Consumption Market Share by Regions (2012-2017) 35
Figure Global Pain Management Drugs Consumption Market Share by Regions (2012-2017) 36
Figure 2012 Global Pain Management Drugs Consumption Market Share by Regions 36
Figure 2016 Global Pain Management Drugs Consumption Market Share by Regions 37
Figure North America Pain Management Drugs Consumption Value (M USD) and Growth Rate (2012-2017) 38
Figure Europe Pain Management Drugs Consumption Value (M USD) and Growth Rate (2012-2017) 39
Figure Asia-Pacific Pain Management Drugs Consumption Value (M USD) and Growth Rate (2012-2017) 40
Figure South America Pain Management Drugs Consumption Value (M USD) and Growth Rate (2012-2017) 41
Figure Middle East and Africa Pain Management Drugs Consumption Value (M USD) and Growth Rate (2012-2017) 42
Table Global Pain Management Drugs Revenue (M USD) by Types (2012-2017) 43
Table Global Pain Management Drugs Revenue Market Share by Types (2012-2017) 43
Figure Revenue Market Share of Pain Management Drugs by Types (2012-2017) 44
Figure 2012 Revenue Market Share of Pain Management Drugs by Types 44
Figure 2016 Revenue Market Share of Pain Management Drugs by Types 45
Figure Global Pain Management Drugs Revenue Growth Rate by Types (2012-2017) 45
Table Global Pain Management Drugs Consumption Value (M USD) by Applications (2012-2017) 46
Table Global Pain Management Drugs Consumption Market Share by Applications (2012-2017) 46
Figure Global Pain Management Drugs Consumption Market Share by Applications (2012-2017) 47
Figure Global Pain Management Drugs Consumption Market Share by Applications in 2012 47
Figure Global Pain Management Drugs Consumption Market Share by Applications in 2016 48
Figure Global Pain Management Drugs Consumption Growth Rate by Applications (2012-2017) 49
Table Pfizer Company Profile 50
Figure Pain Management Drugs Product Picture of Pfizer 51
Table Pain Management Drugs Revenue (M USD), Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Pfizer 2016-2017 51
Table GSK Company Profile 52
Figure Pain Management Drugs Product Picture of GSK 53
Table Pain Management Drugs Revenue (M USD), Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of GSK 2016-2017 54
Table Grunenthal Company Profile 54
Figure Pain Management Drugs Product Picture of Grunenthal 55
Table Pain Management Drugs Revenue (M USD), Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Grunenthal 2016-2017 55
Table Bayer Company Profile 56
Figure Pain Management Drugs Product Picture of Bayer 57
Table Pain Management Drugs Revenue (M USD), Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Bayer 2016-2017 57
Table Sanofi Company Profile 58
Figure Pain Management Drugs Product Picture of Sanofi 59
Table Pain Management Drugs Revenue (M USD), Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Sanofi 2016-2017 59
Table Eli Lilly Company Profile 59
Figure Pain Management Drugs Product Picture of Eli Lilly 61
Table Pain Management Drugs Revenue (M USD), Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Eli Lilly 2016-2017 61
Table AstraZeneca Company Profile 62
Figure Pain Management Drugs Product Picture of AstraZeneca 63
Table Pain Management Drugs Revenue (M USD), Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of AstraZeneca 2016-2017 63
Table Endo Company Profile 64
Figure Pain Management Drugs Product Picture of Endo 65
Table Pain Management Drugs Revenue (M USD), Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Endo 2016-2017 65
Table Merck Company Profile 66
Figure Pain Management Drugs Product Picture of Merck 67
Table Pain Management Drugs Revenue (M USD), Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Merck 2016-2017 67
Table Depomed Company Profile 68
Figure Pain Management Drugs Product Picture of Depomed 69
Table Pain Management Drugs Revenue (M USD), Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Depomed 2016-2017 69
Table Yunnan Baiyao Company Profile 70
Figure Pain Management Drugs Product Picture of Yunnan Baiyao 71
Table Pain Management Drugs Revenue (M USD), Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Yunnan Baiyao 2016-2017 72
Table Teva Company Profile 72
Figure Pain Management Drugs Product Picture of Teva 73
Table Pain Management Drugs Revenue (M USD), Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Teva 2016-2017 73
Table J&J Company Profile 74
Figure Pain Management Drugs Product Picture of J&J 75
Table Pain Management Drugs Revenue (M USD), Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of J&J 2016-2017 76
Table Allergan Company Profile 76
Figure Pain Management Drugs Product Picture of Allergan 77
Table Pain Management Drugs Revenue (M USD), Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Allergan 2016-2017 77
Table Purdue Company Profile 78
Figure Pain Management Drugs Product Picture of Purdue 79
Table Pain Management Drugs Revenue (M USD), Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Purdue 2016-2017 79
Figure Typical Phases from Research to the Market for a Drug Candidate 81
Table Out-of-pocket Preclinical and Clinical Period Cost per Investigational Biopharmaceutical Compound 82
Table Capitalized Preclinical and Clinical Period costs per Investigational Biopharmaceutical Compound 83
Figure Manufacturing Cost Structure of Pain Management Drugs 83
Figure 2016 Manufacturing Labor Cost Per Hour in China as a Proportion of Those in Other Countries (%) 84
Figure Manufacturing Labor Costs in Select Provinces and Countries in 2016 85
Figure 2016 Global Manufacturing Competitiveness Index Rankings by Country 86
Figure US Nonfarm Unit Labor Cost 2014-2016 87
Figure United States Average Hourly Wages (USD/H) 2016-2017 87
Figure China Labor Cost Index 2014-2016 88
Figure China Average Yearly Wages 2006-2016 88
Figure Euro Area Labor Cost 2014-2016 89
Figure Japan Overview of Average Monthly Wages 2012-2017 (JPY Thousand/Month) 89
Figure 2016 Manufacturing Labor Cost Per Hour in China as a Proportion of Those in Other Countries (%) 90
Table 2016 Global Electricity Price of Industry (USD/KW?h) by Country 90
Figure Manufacturing Process Analysis of Pain Management Drugs 91
Figure Pain Management Drugs Industrial Chain Analysis 92
Table Major Buyers of Pain Management Drugs 93
Figure Marketing Channel for Halal Pharmaceuticals 97
Figure Setting Pricing Policy 99
Table Distributors/Traders List 101
Figure Global GDP Growth Rate for 2016 109
Figure Malaysia GDP 2006-2016 (Billion USD) 110
Figure Brunei GDP 2006-2016 (Billion USD) 110
Figure Brazil GDP 2006-2016 (Billion USD) 111
Figure Brazil CPI Change 2016-2017 111
Figure Mexico GDP 2006-2016 (Billion USD) 112
Figure Mexico CPI Change 2012-2016 112
Figure USA GDP 2006-2016 (Billion USD) 113
Figure USA CPI Change 2016-2017 113
Figure EU GDP 2006-2016 (Billion USD) 114
Figure EU CPI Change 2012-2016 114
Figure Germany GDP 2006-2016 (Billion USD) 115
Figure UK GDP 2006-2016 (Billion USD) 115
Figure UK CPI Change 2016-2017 116
Figure Italy GDP 2006-2016 (Billion USD) 116
Figure Italy CPI Change 2016-2017 117
Figure Japan GDP 2006-2016 (Billion USD) 117
Figure Japan CPI Change 2012-2016 118
Figure China GDP 2006-2016 (Billion USD) 118
Figure China CPI Change 2016-2017 119
Figure Global Pain Management Drugs Revenue (M USD) and Growth Rate Forecast (2017-2022) 120
Table Global Pain Management Drugs Revenue (M USD) Forecast by Regions (2017-2022) 120
Table Global Pain Management Drugs Revenue Market Share Forecast by Regions (2017-2022) 121
Figure Global Pain Management Drugs Revenue Market Share Forecast by Regions (2017-2022) 121
Figure Global Pain Management Drugs Revenue Market Share Forecast by Regions in 2022 122
Figure North America Pain Management Drugs Revenue (M USD) and Growth Rate Forecast (2017-2022) 123
Figure Europe Pain Management Drugs Revenue (M USD) and Growth Rate Forecast (2017-2022) 124
Figure Asia-Pacific Pain Management Drugs Revenue (M USD) and Growth Rate Forecast (2017-2022) 125
Figure South America Pain Management Drugs Revenue (M USD) and Growth Rate Forecast (2017-2022) 126
Figure Middle East and Africa Pain Management Drugs Revenue (M USD) and Growth Rate Forecast (2017-2022) 127
Table Global Pain Management Drugs Consumption Value (M USD) Forecast by Regions (2017-2022) 127
Table Global Pain Management Drugs Consumption Market Share Forecast by Regions (2017-2022) 128
Figure Global Pain Management Drugs Consumption Market Share Forecast by Regions (2017-2022) 128
Figure Global Pain Management Drugs Consumption Market Share Forecast by Regions in 2022 129
Figure North America Pain Management Drugs Consumption Value (M USD) and Growth Rate Forecast (2017-2022) 130
Figure Europe Pain Management Drugs Consumption Value (M USD) and Growth Rate Forecast (2017-2022) 131
Figure Asia-Pacific Pain Management Drugs Consumption Value (M USD) and Growth Rate Forecast (2017-2022) 132
Figure South America Pain Management Drugs Consumption Value (M USD) and Growth Rate Forecast (2017-2022) 133
Figure Middle East and Africa Pain Management Drugs Consumption Value (M USD) and Growth Rate Forecast (2017-2022) 134
Table Global Pain Management Drugs Revenue (M USD) Forecast by Types (2017-2022) 134
Table Global Pain Management Drugs Revenue Market Share Forecast by Types (2017-2022) 135
Figure Global Pain Management Drugs Revenue Market Share Forecast by Types (2017-2022) 135
Figure Global Pain Management Drugs Revenue Market Share Forecast by Types in 2022 136
Table Global Pain Management Drugs Consumption Value (M USD) Forecast by Application (2017-2022) 136
Table Global Pain Management Drugs Consumption Forecast by Application (2017-2022) 136
Figure Global Pain Management Drugs Consumption Forecast by Application (2017-2022) 137
Figure Global Pain Management Drugs Consumption Forecast by Application in 2022 138
Table Research Programs/Design for This Report 140
Figure Bottom-up and Top-down Approaches for This Report 142
Figure Data Triangulation 143
Table Key Data Information from Secondary Sources 144
Table Key Data Information from Primary Sources 145

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.

Menu 3

Eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo.